Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-11-06
2007-11-06
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S323000, C514S253090, C514S235500, C544S129000, C544S360000, C540S597000
Reexamination Certificate
active
10992968
ABSTRACT:
The invention is directed to methods to inhibit p38-α kinase using compounds comprising saturated heterocycles coupled to a fused ring system.
REFERENCES:
patent: WO-96/40143 (1996-12-01), None
patent: WO-97/26252 (1997-07-01), None
patent: WO-98/06715 (1998-02-01), None
patent: WO-98/07425 (1998-02-01), None
patent: WO-99/61426 (1999-12-01), None
patent: WO-00/12074 (2000-03-01), None
patent: WO-00/59904 (2000-10-01), None
Chalmers (TiPS vol. 17, pp. 166-172 Apr. 1996.
Chalmers, TiPS (1996) 17:166-172.
Dugar Sundeep
Lu Qing
Luedtke Gregory
Perumattam John
Tan Xuefei
Habte Kahsay
Scios Inc.
LandOfFree
Inhibitors of p38 kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of p38 kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of p38 kinase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3808323